Drug Type Small molecule drug |
Synonyms VV-2003 |
Target |
Mechanism ORAI1 inhibitors(Calcium release-activated calcium channel protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Vivreon BiosciencesStartup |
Active Organization Vivreon BiosciencesStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Preclinical | US | Vivreon BiosciencesStartup | 01 Jul 2017 |